Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Tax ProvisionsTax Rate
Others
Ratios

Qiagen (QGEN) Other Non Operating Income (2016 - 2025)

Historic Other Non Operating Income for Qiagen (QGEN) over the last 17 years, with Q4 2025 value amounting to -$132000.0.

  • Qiagen's Other Non Operating Income fell 10470.59% to -$132000.0 in Q4 2025 from the same period last year, while for Dec 2025 it was -$6.6 million, marking a year-over-year decrease of 79986.47%. This contributed to the annual value of -$6.6 million for FY2025, which is 79986.47% down from last year.
  • As of Q4 2025, Qiagen's Other Non Operating Income stood at -$132000.0, which was down 10470.59% from -$1.3 million recorded in Q3 2025.
  • Qiagen's 5-year Other Non Operating Income high stood at $8.5 million for Q1 2023, and its period low was -$11.0 million during Q2 2023.
  • For the 5-year period, Qiagen's Other Non Operating Income averaged around -$55166.7, with its median value being -$127500.0 (2022).
  • Per our database at Business Quant, Qiagen's Other Non Operating Income soared by 372680.85% in 2023 and then tumbled by 306585.37% in 2025.
  • Quarter analysis of 5 years shows Qiagen's Other Non Operating Income stood at $2.1 million in 2021, then plummeted by 105.82% to -$123000.0 in 2022, then skyrocketed by 1271.54% to $1.4 million in 2023, then soared by 94.66% to $2.8 million in 2024, then tumbled by 104.71% to -$132000.0 in 2025.
  • Its Other Non Operating Income stands at -$132000.0 for Q4 2025, versus -$1.3 million for Q3 2025 and -$1.3 million for Q2 2025.